Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study.

Tatsuya FukudaRyotaro BouchiMasahiro TerashimaYuriko SasaharaMasahiro AsakawaTakato TakeuchiYujiro NakanoMasanori MurakamiIsao MinamiHajime IzumiyamaKoshi HashimotoTakanobu YoshimotoYoshihiro Ogawa

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)

Astellas Pharma Inc. and the Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Keyphrases

insulin resistance
adipose tissue
type diabetes
weight loss
metabolic syndrome
high fat diet induced
healthcare
public health
bariatric surgery
quality improvement
wound healing
weight gain
obese patients
physical activity